Identification of MiRNA Biomarkers for Stomach Adenocarcinoma
Overview
Authors
Affiliations
Background: Stomach adenocarcinoma (STAD) is a common malignant tumor in the world and its prognosis is poor, miRNA plays a role mainly by influencing the expression of mRNAs, and participates in the occurrence and development of tumors. However, reliable miRNA prognostic models for stomach adenocarcinoma remain to be identified.
Results: Using the data from the Cancer Genome Atlas (TCGA), a prognostic model of stomach adenocarcinoma was established including tumor stage and expression levels of 4 miRNAs (hsa-miR-379-3p, hsa-miR-2681-3p, hsa-miR-6499-5p and hsa-miR-6807-3p). A total of 50 ultimate target genes of these miRNAs were obtained through prediction. Enrichment analysis revealed that target genes were mainly concentrated in neural function and TGF-β and FoxO signaling pathways. Survival analysis showed that three model miRNAs (hsa-miR-379-3p, hsa-miR-2681-3p and hsa-miR-6807-3p) and five final target genes (DLC1, LRFN5, NOVA1, POU3F2 and PRICKLE2) were associated with the patient's overall survival outcome.
Conclusions: We used bioinformatics methods to screen new prognostic miRNA markers from TCGA and established a prognostic model of STAD, so as to provide a basis for the diagnosis, prognosis, and treatment of STAD in the future.
Zhang S, Wang J, Zhang H, Li B, Gao S Discov Oncol. 2024; 15(1):550.
PMID: 39397186 PMC: 11471748. DOI: 10.1007/s12672-024-01429-8.
Janyasupab P, Singhanat K, Warnnissorn M, Thuwajit P, Suratanee A, Plaimas K Biomolecules. 2024; 14(8).
PMID: 39199284 PMC: 11352152. DOI: 10.3390/biom14080896.
He M, Zhang H, Zhang Y, Ding Y, Zhang F, Kang Y J Cancer. 2024; 15(8):2391-2402.
PMID: 38495494 PMC: 10937275. DOI: 10.7150/jca.93343.